Dr. Michael G. Santomauro, MD

Dr. Santomauro practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Santomauro's NPI, 1073675591, was assigned on December 14, 2006. Dr. Santomauro graduated from Sidney Kimmel Medical College in 2005. Dr. Santomauro holds California license A96534.

Dr. Santomauro's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Santomauro's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Santomauro is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Santomauro to 3 more hospitals, 5 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Santomauro practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Santomauro's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Santomauro is board certified in urology by the American Board of Urology. Dmand AI has Dr. Santomauro's licenses on file in 4 states: California, Florida, Arizona and Kansas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Santomauro treats.

CMS data shows 664 Medicare services from Dr. Santomauro across 20 procedure codes in 2024, for 335 Medicare patients. Medicare paid $52,081 for them.

CMS counts 335 Medicare patients who saw Dr. Santomauro in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Santomauro's median patient age at 68, with 17% women.

In 2024, Dr. Santomauro wrote 1,003 Medicare Part D claims for 371 patients. 91% of them were for generic drugs. CMS names the drug for 871 of them, across 10 drugs with 11 or more claims each, at $48,865 in total drug cost. In 2023, CMS named 947 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Santomauro for performance year 2024, reported as part of a group. Dr. Santomauro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Santomauro as offering telehealth. CMS counts 18 procedures of prostate resection by Dr. Santomauro, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Santomauro, published from 2011 to 2022. 2011 was the busiest year, with 2. The most frequent topics are Postoperative Complications, Telemedicine and Urologic Surgical Procedures. Dr. Santomauro has published most often in Urology. Dr. Santomauro's most frequent co-authors are Sean Patrick Stroup, MD, Brian K. Auge, MD and Charles Gerard Marguet, MD.

CMS Open Payments shows 358 general payments to Dr. Santomauro from 52 drug and device companies from 2016 to 2025. Education make up the largest share, 72% of the total. Intuitive Surgical, Inc. paid the most, $42,696.

Dmand AI lists 1 award for Dr. Santomauro, most recently AUA International Exchange scholar in 2019.

Dr. Santomauro graduated from Sidney Kimmel Medical College in 2005.

Dr. Santomauro is in network with 16 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.